Jim Oates to B-Lymphocytes
This is a "connection" page, showing publications Jim Oates has written about B-Lymphocytes.
Connection Strength
0.018
-
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan; 62(1):222-33.
Score: 0.018